HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Quinestrol

HCID 9046
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
152-43-2
Standard SMILES
C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C
InChIKey
PWZUUYSISTUNDW-VAFBSOEGSA-N
Molecular formula
C25H32O2
Average molar mass
364.5 g/mol
Monoisotopic mass
364.24023026

Overview

Quinestrol is a 17-hydroxy steroid and a terminal acetylenic compound. It has a role as a xenoestrogen. It is functionally related to a 17beta-estradiol.

Names & identifiers

Preferred name
Quinestrol
IUPAC
(8R,9S,13S,14S,17R)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
English name
Quinestrol
Molecular formula
C25H32O2
Molecular weight
364.52

Names & synonyms

QUINESTROL152-43-2EstrovisEstrovisterPlestrovisEstonEstradiol-17-beta 3-cyclopentyl etherQuinestrolumEstrovis 4000Quinestrolo17-alpha-Ethinylestradiol 3-cyclopentyl etherQuilea
Show more names
eecpew3566EE2CPEqui-leaestrovis4000
W 356617alpha-Ethynylestradiol 3-cyclopentyl etherW-3566DTXSID6046553JR0N7XD5GZ(8R,9S,13S,14S,17R)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-olNSC-759637CHEBI:8716

Database identifiers

CAS
152-43-2
PubChem CID
9046
DTXSID
DTXSID6046553
ChEMBL
CHEMBL1201165
ChEBI
CHEBI:8716
UNII
JR0N7XD5GZ
EC Number
205-803-1
Nikkaji
J5.865C

Properties

Computed structural properties

XLogP
5.3
Topological polar surface area
29.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
3
Heavy atoms
27
Formal charge
0
Complexity
613

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LipidsLipids -> Sterol Lipids [ST] -> Steroids [ST02] -> C18 steroids (estrogens) and derivatives [ST0201]
Solubility1.57e-03 g/L
Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Endocrine DisruptorsPotential endocrine disrupting compound
Melting Point107.5 °C
Physical DescriptionSolid

Physicochemical properties

Melting point
107 · 107-108°
alpha
25 · D25 +5° (c = 0.5 in dioxane)
Boiling point
435.69 °C · 435.69°C (rough estimate)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (60.9%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P263, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 64 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (60.9%)

Toxicology

Health EffectsSide effects include liver and kidney dysfunction, high blood pressure, heart disease, degeneration of the testicles, premature baldness, and acne.
Exposure RoutesAbsorbed following oral administration.
Toxicity Summary · 1 item

Estrogens diffuse into their target cells and interact with a protein receptor (the estrogen receptor). Estrogen interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. The combination of an estrogen with a progestin suppresses the hypothalamic-pituitary system, decreasing the secretion of gonadotropin-releasing hormone (GnRH).

Chemistry & industry

Pharmacology

Pharmacodynamics · 1 item

Quinestrol is the 3-cyclopentyl ether of ethinyl estradiol (the active metabolite). After gastrointestinal absorption, it is stored in adipose tissue where it is slowly released and metabolized principally to the parent compound, ethinyl estradiol. Ethinyl estradiol is a synthetic derivative of the natural estrogen estradiol.

Mechanism of Action · 1 item

Estrogens diffuse into their target cells and interact with a protein receptor (the estrogen receptor). Estrogen interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. The combination of an estrogen with a progestin suppresses the hypothalamic-pituitary system, decreasing the secretion of gonadotropin-releasing hormone (GnRH).

Metabolism/Metabolites · 2 items

Metabolized principally to the parent compound, ethinyl estradiol. Ethinyl estradiol is metabolized in the liver. Quantitatively, the major metabolic pathway for ethinyl estradiol, both in rats and in humans, is aromatic hydroxylation, as it is for the natural estrogens.

Metabolized principally to the parent compound, ethinyl estradiol. Ethinyl estradiol is metabolized in the liver. Quantitatively, the major metabolic pathway for ethinyl estradiol, both in rats and in humans, is aromatic hydroxylation, as it is for the natural estrogens.

MeSH Pharmacological Classification · 1 item

Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Density
1.0693 · 1.0693 (rough estimate)
refractive index
1.448 · 1.4480 (estimate)
storage temp.
2 · 2-8°C
solubility
Chloroform (Slightly), Dioxane (Slightly), DMSO (Slightly), Methanol (Slightly)
pka
13.1 · 13.10±0.40(Predicted)
form
Solid
color
White to Off-White
Merck
14 · 14,8055
CAS DataBase Reference
152 · 152-43-2(CAS DataBase Reference)
FDA UNII
0 N7XD5GZ · JR0N7XD5GZ
Symbol(GHS)
7 · GHS07,GHS08
Signal word
Danger
Hazard statements
302 · H302+H312+H332-H350-H360
Precautionary statements
201 · P201-P280-P301+P312-P302+P352+P312-P304+P340+P312-P308+P313
Hazard Codes
T
Risk Statements
45 · 45-61-20/21/22-46
Safety Statements
53 · 53-22-36/37/39-45
WGK Germany
3 · 3
RTECS
8948000 · RC8948000
Signs and SymptomsSymptoms of overdose include nausea and vomiting, and withdrawal bleeding may occur in females.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Safety data

wgk
3
rtecs
RC8948000
risk_code
45-61-20/21/22-46
Signal word
Danger
Symbol(GHS)
GHS07,GHS08
hazard_code
T
safety_code
53-22-36/37/39-45
Hazard statements
H302+H312+H332-H350-H360
Precautionary statements
P201-P280-P301+P312-P302+P352+P312-P304+P340+P312-P308+P313
Absorption, Distribution and ExcretionAbsorbed following oral administration.
Cellular LocationsCytoplasm

Uses & manufacturing

UsesUsed in hormone replacement therapy, treating symptoms of menopause such as hot flashes. Also used to treat breast and prostate cancer.
Applications · 3 items

DescriptionQuinestrol is a synthetic estrogen that is effective in hormone replacement therapy. It is a 3-cyclopentyl ether of ethynyl estradiol. After gastrointestinal absorption, it is stored in adipose tissue, where it is slowly released and metabolized in the liver to its active form, ethinyl estradiol. Quinestrol has found limited use in suppressing lactation in postpartum women and, in combination with synthetic progestogens, as contraceptive therapy, although additional studies are needed for both applications.

Usesantibacterial, antimycoplasmal, isoleucyl-tRNA synthetase inhibitor

UsesQuinestrol is an estrogen-like compound.

Upstream & downstream products

Upstream raw materials

TetrahydrofuranBromocyclopentaneEstra-1,3,5(10)-trien-17-one, 3-(cyclopentyloxy)-TrimethylsilylacetylenePotassium hydroxiden-ButyllithiumMethanol

Additional notes

DefinitionChEBI: Quinestrol is a 17-hydroxy steroid and a terminal acetylenic compound. It has a role as a xenoestrogen. It is functionally related to a 17beta-estradiol.